Literature DB >> 22187337

Saitohin polymorphism and executive dysfunction in schizophrenia.

Marta Bosia1, Mariachiara Buonocore, Carmelo Guglielmino, Adele Pirovano, Cristina Lorenzi, Alessandra Marcone, Placido Bramanti, Stefano F Cappa, Eugenio Aguglia, Enrico Smeraldi, Roberto Cavallaro.   

Abstract

Saitohin (STH) is an intronless gene nested within the human tau gene, which contains a single nucleotide polymorphism (A/G), suggested to be involved in the physiopathology and clinical course of several neurodegenerative and neuropsychiatric diseases. Recently, an association between this polymorphism and frontal hypoperfusion and clinical prognosis in frontotemporal dementia was reported. The present study sought to evaluate the possible role of the STH polymorphism as a concurring factor of cognitive decline in schizophrenia, a disease sharing both early psychotic manifestations, a core deficit of executive functions and hypofrontality with frontotemporal lobe dementia. 220 clinically stabilized patients with schizophrenia were assessed with the Wisconsin Card Sorting Test (WCST) for evaluation of executive functions and compared for STH allele frequency with 48 patients affected by frontotemporal dementia and 47 healthy subjects. There was no significant difference in allelic distribution between the healthy controls and all other groups, while we observed a significantly greater frequency of G allele among both patients with frontotemporal dementia (p = 0.037) and schizophrenia patients with poor performances of WCST (p = 0.044), compared to schizophrenia patients with best WCST performances. Among the patients with schizophrenia, stratified for age and gender, the STH polymorphism resulted in a significant predictor of WCST performance (p = 0.007). These results suggest a possible contribution of STH gene products on the heterogeneity of core frontal executive functions deterioration, probably through complex interactions with mechanism involved in neurodevelopment and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187337     DOI: 10.1007/s10072-011-0893-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

1.  Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy.

Authors:  R de Silva; A Hope; A Pittman; M E Weale; H R Morris; N W Wood; A J Lees
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

2.  Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6.

Authors:  Lei Gao; Sze-Wah Tse; Christopher Conrad; Athena Andreadis
Journal:  J Biol Chem       Date:  2005-09-26       Impact factor: 5.157

3.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study.

Authors:  Roberto Cavallaro; Paolo Cavedini; Pietro Mistretta; Tommaso Bassi; Sara Monica Angelone; Alessandro Ubbiali; Laura Bellodi
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

5.  Relationship of good and poor Wisconsin Card Sorting Test performance to illness duration in schizophrenia: a cross-sectional analysis.

Authors:  Paolo Stratta; Luca Arduini; Enrico Daneluzzo; Osvaldo Rinaldi; Andrea di Genova; Alessandro Rossi
Journal:  Psychiatry Res       Date:  2004-01-01       Impact factor: 3.222

6.  Establishing short-term prognosis in Frontotemporal Lobar Degeneration spectrum: role of genetic background and clinical phenotype.

Authors:  Barbara Borroni; Mario Grassi; Chiara Agosti; Enrico Premi; Silvana Archetti; Antonella Alberici; Giuseppe Bellelli; Luigi Caimi; Monica Di Luca; Alessandro Padovani
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

7.  Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.

Authors:  Michael A Rapp; Michal Schnaider-Beeri; Dushyant P Purohit; Abraham Reichenberg; Susan R McGurk; Vahram Haroutunian; Philip D Harvey
Journal:  Schizophr Res       Date:  2010-01       Impact factor: 4.939

8.  HD phenocopies--possible role of Saitohin gene.

Authors:  N Janković; M Kecmanović; R Dimitrijević; M Keckarević Marković; V Dobricić; D Keckarević; D Savić Pavicević; S Romac
Journal:  Int J Neurosci       Date:  2008-03       Impact factor: 2.292

9.  Reelin activates SRC family tyrosine kinases in neurons.

Authors:  Hans H Bock; Joachim Herz
Journal:  Curr Biol       Date:  2003-01-08       Impact factor: 10.834

10.  Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia.

Authors:  Katherine H Karlsgodt; Jacqueline Sanz; Theo G M van Erp; Carrie E Bearden; Keith H Nuechterlein; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2009-02-03       Impact factor: 4.939

View more
  3 in total

Review 1.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

2.  Association of rs62063857 variant of the saitohin gene with Parkinson's disease.

Authors:  Ezgi Sonmez; Mavi Deniz Ozel; Eylul Ece Islek; Ali Sazci; Halil Atilla Idrisoglu
Journal:  Cell Mol Neurobiol       Date:  2014-08-29       Impact factor: 5.046

3.  COMT and STH polymorphisms interaction on cognition in schizophrenia.

Authors:  Marta Bosia; Alessandro Pigoni; Adele Pirovano; Cristina Lorenzi; Marco Spangaro; Mariachiara Buonocore; Margherita Bechi; Federica Cocchi; Carmelo Guglielmino; Placido Bramanti; Enrico Smeraldi; Roberto Cavallaro
Journal:  Neurol Sci       Date:  2014-10-05       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.